Lipid-Lowering Drug Reduces Glucose Levels

WASHINGTON — Colesevelam (WelChol), approved in the United States since 2000 for lowering lipid levels, also appears to reduce postprandial glucose in patients with type 2 diabetes, Dr. Franklin Zieve and his associates reported in a poster at the annual scientific sessions of the American Diabetes Association.